Search Results

Filter
  • 1-10 of  836 results for ""Therapeutic Equivalency""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers.

  • Authors : Wang Z; Clinical Pharmacokinetics Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; Zhang Y

Subjects: Pyridines*/Pyridines*/Pyridines*/pharmacokinetics ; Pyridines*/Pyridines*/Pyridines*/administration & dosage ; Pyridines*/Pyridines*/Pyridines*/adverse effects

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1317-1323. Date of Electronic Publication: 2024 Oct 23.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.

  • Authors : Lim HS; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.; Department of Medical Science, Chungnam National University College of Medicine, Daejeon, Republic of Korea.

Subjects: Amlodipine*/Amlodipine*/Amlodipine*/pharmacokinetics ; Amlodipine*/Amlodipine*/Amlodipine*/administration & dosage ; Amlodipine*/Amlodipine*/Amlodipine*/adverse effects

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1345-1354. Date of Electronic Publication: 2024 Sep 27.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

New Ustekinumab Biosimilar Candidate FYB202: Pharmacokinetic Equivalence Demonstrated in a Randomized, Double-Blind, Parallel-Group, Single-Dose Trial in Healthy Subjects.

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/pharmacokinetics ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/administration & dosage ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/adverse effects

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1308-1316. Date of Electronic Publication: 2024 Sep 19.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A Bioequivalence Trial of Lenvatinib Mesylate Capsules in Healthy Subjects Under Fasting and Postprandial Conditions.

  • Authors : Shao J; Nanjing Caremo Biomedical Co., Ltd., Nanjing, China.; Jiangsu Dongke Kangde Pharmaceutical Co., Ltd., Nanjing, China.

Subjects: Therapeutic Equivalency* ; Quinolines*/Quinolines*/Quinolines*/pharmacokinetics ; Quinolines*/Quinolines*/Quinolines*/administration & dosage

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1324-1330. Date of Electronic Publication: 2024 Sep 10.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers.

  • Authors : Hu S; Phase I Clinical Trial Laboratory, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology; Hubei Clinical Research Center for Infectious Diseases

Subjects: Therapeutic Equivalency* ; Cross-Over Studies* ; Healthy Volunteers*

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1339-1344. Date of Electronic Publication: 2024 Sep 05.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers.

Subjects: Therapeutic Equivalency* ; Cross-Over Studies* ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/pharmacokinetics

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1331-1338. Date of Electronic Publication: 2024 Aug 14.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Oral solid dosage form using alternate crystalline neratinib maleate anhydrous form: Pharmaceutical, bioequivalent, and clinical perspectives.

  • Authors : Ming C; Convalife Pharmaceuticals, Shanghai, China.; Liu Z

Subjects: Therapeutic Equivalency* ; Quinolines*/Quinolines*/Quinolines*/chemistry ; Quinolines*/Quinolines*/Quinolines*/pharmacokinetics

  • Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2024 Nov; Vol. 38 (11), pp. e5988. Date of Electronic Publication: 2024 Aug 20.Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Evaluation of model-integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methods.

Subjects: Therapeutic Equivalency* ; Models, Biological* ; Computer Simulation*

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Oct; Vol. 13 (10), pp. 1748-1761. Date of Electronic Publication: 2024 Aug 28.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified-Release Dosage Form.

  • Authors : Purohit V; Translational Clinical Sciences, Pfizer Worldwide Research and Development, Groton, Connecticut, USA.; Sagawa K

Subjects: Piperidines*/Piperidines*/Piperidines*/pharmacokinetics ; Piperidines*/Piperidines*/Piperidines*/administration & dosage ; Pyrimidines*/Pyrimidines*/Pyrimidines*/pharmacokinetics

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 996-1004. Date of Electronic Publication: 2024 May 26.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A Randomized, Cross-Over Study Investigating the Comparability of Somatrogon-ghla in 2 Different Drug Product Presentations.

Subjects: Cross-Over Studies* ; Human Growth Hormone*/Human Growth Hormone*/Human Growth Hormone*/administration & dosage ; Human Growth Hormone*/Human Growth Hormone*/Human Growth Hormone*/pharmacokinetics

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Oct; Vol. 13 (10), pp. 1108-1114. Date of Electronic Publication: 2024 Jun 24.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  836 results for ""Therapeutic Equivalency""